Deprescribing in older people

dianagosalvez Diana Gosalvez Prados última modificación 29/09/2016 12:46

Older people with chronic disease have great potential to benefit from their medications but are also at high risk of harm from their medications. The use of medications is particularly important for symptom control and disease progression in older people. Under-treatment means older people can miss out on the potential benefits of useful medications, while over-treatment (polypharmacy) puts them at increased risk of harm. Deprescribing attempts to balance the potential for benefit and harm by systematically withdrawing inappropriate medications with the goal of managing polypharmacy and improving outcomes. The evidence base for deprescribing in older people is growing. Studies to reduce polypharmacy have used a range of methods. Most evidence for deprescribing relates to the withdrawal of specific medications, and evidence supports attempts to deprescribe potentially inappropriate medicines (such as long-term benzodiazepines). There is also evidence that polypharmacy can be reduced by withdrawing specific medications using individualised interventions. More work is needed to identify the sub-groups of older people who may most benefit from deprescribing and the best approaches to undertaking the deprescribing interventions.

Page AT, Potter K, Clifford R, Etherton-Beer C. Deprescribing in older people Maturitas. 2016 Sep;91:115-34. Available at: http://www.sciencedirect.com/science/article/pii/S0378512216301384


Artículo

29/09/2016

Page AT, Potter K, Clifford R, Etherton-Beer C.

Oceanía